Future of tissue engineering in rheumatic diseases

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Rheumatology

Background:

• Rheumatoid arthritis and osteoarthritis cause joint destruction via chronic inflammation and degeneration.
• Current therapies like anti-inflammatories and surgery have limitations in tissue regeneration and long-term effectiveness.
• Tissue engineering presents novel strategies for cartilage and bone defect repair.

Purpose of the Study:

• To review state-of-the-art and future in situ mesenchymal stem cell-based tissue engineering for joint repair.
• To highlight advancements beyond cell suspensions, including biomaterials combined with cells.
• To focus on applications for patients with rheumatic diseases.

Main Methods:

• Review of current literature on tissue engineering for joint repair.
• Analysis of in situ mesenchymal stem cell-based approaches.
• Evaluation of biomaterial-cell combinations for cartilage and bone regeneration.

Main Results:

• Mesenchymal stem cells combined with biomaterials are clinically applied for joint repair.
• Tissue engineering offers promising alternatives to conventional treatments.
• In situ approaches are advancing for regenerative strategies in rheumatic diseases.

Conclusions:

• Mesenchymal stem cell-based tissue engineering shows significant potential for joint repair in rheumatic diseases.
• Future research should focus on optimizing in situ strategies for enhanced tissue regeneration.
• This field offers hope for improved long-term outcomes in joint disease management.